Cure My Disease

Don't miss your cure!

 Log in / Sign up

Arm rehab showdown: which therapy boosts hand function in kids with CP?

NCT ID NCT07694804

Disease control Sponsor: Ibadat International University, Islamabad Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 10, 2026 · Last updated Jul 14, 2026 · Updated 2 times

Summary

This study tests two rehabilitation methods—proprioceptive neuromuscular facilitation (PNF) and task-oriented training (TOT)—alone or combined, to improve arm and hand function in children aged 6–12 with spastic diplegic cerebral palsy. Sixty-three participants will receive 45-minute sessions three times a week for six weeks. Researchers will measure movement quality, daily independence, and joint range of motion to see which approach works best.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Proprioceptive Neuromuscular Facilitation (PNF) and Task-Oriented Training (TOT)
What this could lead to
If one approach proves superior, it could guide therapists toward the most effective rehab strategy for improving arm function and daily independence in children with cerebral palsy.
What could go wrong
This is a small, early-stage trial (63 children) comparing established techniques, so differences between groups may be small or not clinically meaningful. Results may not apply to all children with CP.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 63 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

6 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Children aged 6 to 12 years. * Clinical diagnosis of spastic diplegic cerebral palsy. * Gross Motor Function Classification System (GMFCS) Levels I-III. * Ability to understand and follow simple verbal instructions. * Medically stable and able to participate in physiotherapy sessions. * Parent or legal guardian willing to provide written informed consent. Exclusion Criteria: * Orthopedic surgery involving the upper or lower extremities within the previous 6 months. * Botulinum toxin injections administered within the previous 6 months. * Severe visual, hearing, or cognitive impairments that would interfere with assessment or treatment. * Uncontrolled epilepsy or other unstable neurological or medical conditions. * Fixed upper extremity contractures or musculoskeletal deformities preventing participation in the intervention. * Participation in another structured upper extremity rehabilitation program during the study period. * Failure to obtain informed consent from a parent or legal guardian.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cerebral palsy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral palsy spastic diplegia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cerebral palsy Spastic diplegia

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Helping Hand Institute of Rehabilitation

    RECRUITING

    Mansehra, KPK, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.